We credit our success in bringing important new products to market on two key strengths.
First, we have a proven track record of identifying and licensing innovative compounds.
Second, our comprehensive research, development, and regulatory capabilities enable us
to address the requisite tasks for each of our drug candidates and rapidly advance our
Marco Taglietti, M.D.
Executive Vice President, Drug Development
and Research, and Chief Medical Officer